Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Medicure (MCUJF) over the last 12 years, with Q3 2025 value amounting to $279685.2.

  • Medicure's Gains from Investment Securities rose 60871.26% to $279685.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $279685.2, marking a year-over-year increase of 43996.11%. This contributed to the annual value of -$44806.7 for FY2023, which is 3316.43% up from last year.
  • According to the latest figures from Q3 2025, Medicure's Gains from Investment Securities is $279685.2, which was up 60871.26% from $265590.2 recorded in Q2 2025.
  • In the past 5 years, Medicure's Gains from Investment Securities registered a high of $966001.8 during Q3 2021, and its lowest value of -$1.0 million during Q4 2021.
  • In the last 5 years, Medicure's Gains from Investment Securities had a median value of $20140.1 in 2023 and averaged $175588.0.
  • As far as peak fluctuations go, Medicure's Gains from Investment Securities crashed by 44496.1% in 2021, and later surged by 144538.76% in 2025.
  • Medicure's Gains from Investment Securities (Quarter) stood at -$1.0 million in 2021, then soared by 103.11% to $32414.9 in 2022, then crashed by 61.48% to $12487.1 in 2023, then crashed by 375.17% to -$34360.8 in 2024, then soared by 913.97% to $279685.2 in 2025.
  • Its last three reported values are $279685.2 in Q3 2025, $265590.2 for Q2 2025, and -$34148.9 during Q1 2025.